"These guidelines will significantly change the way we treat heart diseases," said senior heart surgeon Dr Ramakanta Panda. However, a few doctors felt that these guidelines would only help increase the sale of statins—the cholesterol-control drugs that have in the last decade revolutionised cardiac care.
So, why are the new guidelines being hailed as a "tectonic shift" that will "fundamentally reshape" treatment of heart patients? The guidelines make doctors work easy by identifying four groups that need statins immediately: patients with existing heart disease, those with an LDL or "bad" cholesterol level of 190mg/dL or higher, those with Type 2 diabetes and are 40-75 years of age, and those with an estimated 10-year risk of heart disease of 7.5% or higher and are 40-75 years of age.
Cardiologist Ganesh Kumar from Powai's L H Hiranandani Hospital said, "Earlier,if a patient had diabetes, we had to bring down his/her levels down to 70. There was a lot of calculation to be done."